BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

607 related articles for article (PubMed ID: 23436823)

  • 1. Application value of 3T ¹H-magnetic resonance spectroscopy in diagnosing breast tumors.
    Vassiou K; Tsougos I; Kousi E; Vlychou M; Athanasiou E; Theodorou K; Arvanitis DL; Fezoulidis IV
    Acta Radiol; 2013 May; 54(4):380-8. PubMed ID: 23436823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined DCE-MRI and single-voxel 2D MRS for differentiation between benign and malignant breast lesions.
    Lipnick S; Liu X; Sayre J; Bassett LW; Debruhl N; Thomas MA
    NMR Biomed; 2010 Oct; 23(8):922-30. PubMed ID: 20878970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiparametric breast MRI with 3T: Effectivity of combination of contrast enhanced MRI, DWI and 1H single voxel spectroscopy in differentiation of Breast tumors.
    Aribal E; Asadov R; Ramazan A; Ugurlu MÜ; Kaya H
    Eur J Radiol; 2016 May; 85(5):979-86. PubMed ID: 27130059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved diagnostic accuracy in differentiating malignant and benign lesions using single-voxel proton MRS of the breast at 3 T MRI.
    Suppiah S; Rahmat K; Mohd-Shah MN; Azlan CA; Tan LK; Aziz YF; Vijayananthan A; Wui AL; Yip CH
    Clin Radiol; 2013 Sep; 68(9):e502-10. PubMed ID: 23706826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative Investigation of Single Voxel Magnetic Resonance Spectroscopy and Dynamic Contrast Enhancement MR Imaging in Differentiation of Benign and Malignant Breast Lesions in a Sample of Iranian Women.
    Faeghi F; Baniasadipour B; Jalalshokouhi J
    Asian Pac J Cancer Prev; 2015; 16(18):8335-8. PubMed ID: 26745081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 1H MR spectroscopy and diffusion-weighted imaging of the breast: are they useful tools for characterizing breast lesions before biopsy?
    Tozaki M; Fukuma E
    AJR Am J Roentgenol; 2009 Sep; 193(3):840-9. PubMed ID: 19696300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preliminary study of 3T 1H MR spectroscopy in bone and soft tissue tumors.
    Qi ZH; Li CF; Li ZF; Zhang K; Wang Q; Yu DX
    Chin Med J (Engl); 2009 Jan; 122(1):39-43. PubMed ID: 19187615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of spatiotemporal changes for the classification of dynamic contrast-enhanced magnetic-resonance breast lesions.
    Milenković J; Hertl K; Košir A; Zibert J; Tasič JF
    Artif Intell Med; 2013 Jun; 58(2):101-14. PubMed ID: 23548472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined dynamic contrast enhanced breast MR and proton spectroscopic imaging: a feasibility study.
    Jacobs MA; Barker PB; Argani P; Ouwerkerk R; Bhujwalla ZM; Bluemke DA
    J Magn Reson Imaging; 2005 Jan; 21(1):23-8. PubMed ID: 15611934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proton MR spectroscopy with choline peak as malignancy marker improves positive predictive value for breast cancer diagnosis: preliminary study.
    Bartella L; Morris EA; Dershaw DD; Liberman L; Thakur SB; Moskowitz C; Guido J; Huang W
    Radiology; 2006 Jun; 239(3):686-92. PubMed ID: 16603660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The contribution of diffusion tensor imaging and magnetic resonance spectroscopy for the differentiation of breast lesions at 3T.
    Tsougos I; Svolos P; Kousi E; Athanassiou E; Theodorou K; Arvanitis D; Fezoulidis I; Vassiou K
    Acta Radiol; 2014 Feb; 55(1):14-23. PubMed ID: 23864060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Magnetic resonance spectroscopy of the breast at 3T: pre- and post-contrast evaluation for breast lesion characterization.
    Kousi E; Tsougos I; Vasiou K; Theodorou K; Poultsidi A; Fezoulidis I; Kappas C
    ScientificWorldJournal; 2012; 2012():754380. PubMed ID: 22645448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved diagnostic accuracy with multiparametric magnetic resonance imaging of the breast using dynamic contrast-enhanced magnetic resonance imaging, diffusion-weighted imaging, and 3-dimensional proton magnetic resonance spectroscopic imaging.
    Pinker K; Bogner W; Baltzer P; Gruber S; Bickel H; Brueck B; Trattnig S; Weber M; Dubsky P; Bago-Horvath Z; Bartsch R; Helbich TH
    Invest Radiol; 2014 Jun; 49(6):421-30. PubMed ID: 24566292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved differentiation of benign and malignant breast tumors with multiparametric 18fluorodeoxyglucose positron emission tomography magnetic resonance imaging: a feasibility study.
    Pinker K; Bogner W; Baltzer P; Karanikas G; Magometschnigg H; Brader P; Gruber S; Bickel H; Dubsky P; Bago-Horvath Z; Bartsch R; Weber M; Trattnig S; Helbich TH
    Clin Cancer Res; 2014 Jul; 20(13):3540-9. PubMed ID: 24963052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The added value of quantitative multi-voxel MR spectroscopy in breast magnetic resonance imaging.
    Dorrius MD; Pijnappel RM; van der Weide Jansen MC; Jansen L; Kappert P; Oudkerk M; Sijens PE
    Eur Radiol; 2012 Apr; 22(4):915-22. PubMed ID: 22076317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of breast malignancy: diagnostic MR protocol for improved specificity.
    Huang W; Fisher PR; Dulaimy K; Tudorica LA; O'Hea B; Button TM
    Radiology; 2004 Aug; 232(2):585-91. PubMed ID: 15205478
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Montemezzi S; Cavedon C; Camera L; Meliadò G; Caumo F; Baglio I; Sardanelli F
    Radiol Med; 2017 Mar; 122(3):161-170. PubMed ID: 27981485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The evaluation of human breast lesions with magnetic resonance imaging and proton magnetic resonance spectroscopy.
    Cecil KM; Schnall MD; Siegelman ES; Lenkinski RE
    Breast Cancer Res Treat; 2001 Jul; 68(1):45-54. PubMed ID: 11678308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiparametric MR Imaging with High-Resolution Dynamic Contrast-enhanced and Diffusion-weighted Imaging at 7 T Improves the Assessment of Breast Tumors: A Feasibility Study.
    Pinker K; Baltzer P; Bogner W; Leithner D; Trattnig S; Zaric O; Dubsky P; Bago-Horvath Z; Rudas M; Gruber S; Weber M; Helbich TH
    Radiology; 2015 Aug; 276(2):360-70. PubMed ID: 25751227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differentiation between benign and malignant breast lesions using quantitative diffusion-weighted sequence on 3 T MRI.
    Tan SL; Rahmat K; Rozalli FI; Mohd-Shah MN; Aziz YF; Yip CH; Vijayananthan A; Ng KH
    Clin Radiol; 2014 Jan; 69(1):63-71. PubMed ID: 24156797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.